Comparative effectiveness of five fecal immunochemical tests using colonoscopy as the gold standard: study protocol.

Abstract

BACKGROUND:

There are nearly 50,000 colorectal cancer (CRC) deaths in the United States each year. CRC is curable if detected in its early stages. Fecal immunochemical tests (FITs) can detect precursor lesions and many can be analyzed at the point-of-care (POC) in physician offices. However, there are few data to guide test selection. Broader use of FITs could make CRC screening more accessible, especially in resource-poor settings.

METHODS:

A total of 3600 racially and ethnically diverse individuals aged 50 to 85 years having either a screening or surveillance colonoscopy will be recruited. Each participant will complete five FITs on a single stool sample. Test characteristics for each FIT for advanced colorectal neoplasia (ACN) will be calculated using colonoscopy as the gold standard.

RESULTS:

We have complete data from a total of 2990 individuals. Thirty percent are Latino and 5.3% are black/African American. We will present full results once the study is completed.

CONCLUSIONS:

Our focus in this study is how well FITs detect ACN, using colonoscopy as the gold standard. Four of the five FITs being used are POC tests. Although FITs have been shown to have acceptable performance, there is little data to guide which ones have the best test characteristics and colonoscopy is the main CRC screening test used in the United States. Use of FITs will allow broader segments of the population to access CRC screening because these tests require no preparation, are inexpensive, and can be collected in the privacy of one's home. Increasing CRC screening uptake will reduce the burden of advanced adenomas and colorectal cancer.

• Authors: Barcey T Levy, Jeanette M Daly, Yinghui Xu, Seth D Crockett, Richard M Hoffman, Jeffrey D Dawson, Kim Parang, Navkiran K Shokar, Daniel S Reuland, Marc J Zuckerman, Avraham Levin
• Journal: Contemporary clinical trials (Contemp Clin Trials) Vol. 106 Pg. 106430 (07 2021) ISSN: 1559-2030 [Electronic] United States
• PMID: 33974994 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
• Copyright: Copyright © 2021 Elsevier Inc. All rights reserved.

Topics

• Colonoscopy
• Colorectal Neoplasms (diagnosis)
• Early Detection of Cancer
• Feces
• Humans
• Occult Blood